Page last updated: 2024-11-05

zonisamide and Decreased Muscle Tone

zonisamide has been researched along with Decreased Muscle Tone in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Early-onset severe spinocerebellar ataxia 42 with neurodevelopmental deficits (SCA42ND, MIM#604065) is an ultrarare autosomal dominant syndrome related to de novo CACNA1G gain-of-function pathogenic variants."1.62Early-onset severe spinocerebellar ataxia 42 with neurodevelopmental deficits (SCA42ND): Case report, pharmacological trial, and literature review. ( Bolasell, M; Casas-Alba, D; Fernández-Fernández, JM; López-Sala, L; Mari-Vico, R; Martínez-Monseny, AF; Martorell, L; Muchart, J; Pérez-Ordóñez, M; Serrano, M, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Casas-Alba, D1
López-Sala, L1
Pérez-Ordóñez, M1
Mari-Vico, R1
Bolasell, M1
Martínez-Monseny, AF1
Muchart, J1
Fernández-Fernández, JM1
Martorell, L1
Serrano, M1

Other Studies

1 other study available for zonisamide and Decreased Muscle Tone

ArticleYear
Early-onset severe spinocerebellar ataxia 42 with neurodevelopmental deficits (SCA42ND): Case report, pharmacological trial, and literature review.
    American journal of medical genetics. Part A, 2021, Volume: 185, Issue:1

    Topics: Age of Onset; Alleles; Calcium Channels, T-Type; Child, Preschool; Epilepsy; Female; Gain of Functio

2021